These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2760170

  • 1. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly.
    van Liessum PA, Hopman WP, Pieters GF, Jansen JB, Smals AG, Rosenbusch G, Kloppenborg PW, Lamers CB.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):557-62. PubMed ID: 2760170
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Postprandial exocrine pancreatic function during long-term treatment with the somatostatin analogue SMS 201-995 in acromegalic patients.
    Van Liessum PA, Hopman WP, Pieters GF, Smals AG, Tangerman A, Jansen JB, Rosenbusch G, Lamers CB.
    Eur J Clin Invest; 1990 Aug; 20(4):348-53. PubMed ID: 2121494
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201-995).
    Hopman WP, van Liessum PA, Pieters GF, Smals AG, Tangerman A, Jansen JB, Rosenbusch G, Lamers CB, Kloppenborg PW.
    Digestion; 1990 Aug; 45 Suppl 1():72-6. PubMed ID: 2185969
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.
    Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2768-75. PubMed ID: 7673422
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients.
    Shi YF, Zhu XF, Harris AG, Zhang JX, Dai Q.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099
    [Abstract] [Full Text] [Related]

  • 12. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B, Mawe GM, Riepl RL.
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.
    Ewins DL, Javaid A, Coskeran PB, Shah S, Butler J, Deprez PH, Miell J, Calam J, Barrett JJ, Dawson JM.
    Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261
    [Abstract] [Full Text] [Related]

  • 16. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function.
    Gielkens HA, Eddes EH, Vecht J, van Oostayen JA, Lamers CB, Masclee AA.
    J Hepatol; 1997 Aug; 27(2):306-12. PubMed ID: 9288605
    [Abstract] [Full Text] [Related]

  • 17. Effect of somatostatin on postprandial gallbladder relaxation.
    Vu MK, Van Oostayen JA, Biemond I, Masclee AA.
    Clin Physiol; 2001 Jan; 21(1):25-31. PubMed ID: 11168293
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.